Health
Novel microfluidic approach to fight cancer could greatly benefit patients – News-Medical.Net
CAR-T biotherapeutics company Carina Biotech and researchers at the University of South Australia have developed a novel approach based on microfluidic technolo…
Reviewed by Emily Henderson, B.Sc.Oct 20 2020
CAR-T biotherapeutics company Carina Biotech and researchers at the University of South Australia have developed a novel approach based on microfluidic technology to “purify” the immune cells of patients in the fight against cancer.
UniSA’s Future Industries Institute PhD student Mona Elsemary has developed a microfluidic approach to purify chimeric antigen receptor (CAR-T) cells, the bioengineered immune cells that are the basis of groundbreaking …
-
General21 hours agoStar Wars’ fascist dystopia has never felt closer than in new season of Andor
-
Noosa News21 hours agoFarmers call for policy reform across multiple sectors as productivity collapses
-
Business19 hours ago10 high-conviction ASX dividend shares to buy for passive income today
-
Noosa News21 hours agoQueensland Premier David Crisafulli keeps clear of Coalition chaos in Canberra